SEC Form D · filed October 12, 2023
RedHill Biopharma Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (36)
Gilead D. Raday · Tel Aviv, L3ExecKenneth Reed · Tel Aviv, L3DirectorOfer Tsimchi · Tel Aviv, L3DirectorEric Swenden · Tel Aviv, L3DirectorReza D. Fathi · Tel Aviv, L3ExecAlla D. Felder · Tel Aviv, L3DirectorGuy D. Goldberg · Tel Aviv, L3ExecAdi D. Frish · Tel Aviv, L3ExecRick D. Scruggs · Tel Aviv, L3Exec · DirectorRazi Ingber · Tel Aviv, L3ExecShmuel Cabilly · Tel Aviv, L3DirectorDror Ben-Asher · Tel Aviv, L3Exec · DirectorCleon N. Daskalakis · Boston, MAExecJeffrey N. Vale · Atlanta, GAExecGaurav Gambhir · Philadelphia, PADirectorJoshua E. Wyss · Mill Valley, CADirectorMohamed Arafa · Amstelveen, P7DirectorBrandon Contino · Turtle Creek, PAExecKen Johnson · Franklin, MIDirectorBruce W. Snyder · Seattle, WAExec · DirectorRazi Ingber · Tel Aviv, L3ExecPeter R. Kagan · Tulsa, OKExecIngrid Mulder · Amstelveen, P7Exec · DirectorAldo Zini · Turtle Creek, PADirectorJosh S. Stein · Palo Alto, CADirectorSteven A. Anderson · SOUTH PASADENA, CADirectorJohn C. Power · VACAVILLE, CAExec · DirectorBrian C. Power · VACAVILLE, CADirectorJacob S. Horne · SAN FRANCISCO, CAExecDavid Meredith · NEWPORT BEACH, CAExecRick Taketa · CORONA DEL MAR, CAExecDarren O'Brien · WAN CHAI, Hong KongDirectorSimone Blank · NEWPORT BEACH, CAExec · DirectorJost Fischer · NEWPORT BEACH, CADirectorDouglas Buchalter · Asheville, NCExecSusan C. Schnabel · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗